ACADIA Pharmaceuticals SG&A Expense (TTM) Trends

ACADIA Pharmaceuticals Inc (ACAD)

16.25 -0.12 (-0.73%) USD | NASDAQ | Jun 28, 16:00

16.24 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2004. Upgrade now.

Date	Value
March 31, 2024	413.31M
December 31, 2023	406.56M
September 30, 2023	399.50M
June 30, 2023	379.71M
March 31, 2023	373.65M
December 31, 2022	369.09M
September 30, 2022	370.60M
June 30, 2022	374.16M
March 31, 2022	381.05M
December 31, 2021	396.03M
September 30, 2021	410.87M
June 30, 2021	410.79M
March 31, 2021	398.35M
December 31, 2020	388.66M
September 30, 2020	359.78M
June 30, 2020	350.88M
March 31, 2020	334.52M
December 31, 2019	325.64M
September 30, 2019	308.04M
June 30, 2019	296.43M
March 31, 2019	297.92M
December 31, 2018	265.76M
September 30, 2018	258.18M
June 30, 2018	258.68M
March 31, 2018	250.33M

Date	Value
December 31, 2017	255.06M
September 30, 2017	246.04M
June 30, 2017	234.98M
March 31, 2017	224.62M
December 31, 2016	186.46M
September 30, 2016	151.41M
June 30, 2016	121.18M
March 31, 2016	91.53M
December 31, 2015	88.30M
September 30, 2015	76.11M
June 30, 2015	63.86M
March 31, 2015	50.69M
December 31, 2014	32.75M
September 30, 2014	26.60M
June 30, 2014	22.34M
March 31, 2014	16.89M
December 31, 2013	12.72M
September 30, 2013	10.74M
June 30, 2013	8.43M
March 31, 2013	7.49M
December 31, 2012	6.999M
September 30, 2012	6.179M
June 30, 2012	6.213M
March 31, 2012	7.386M
December 31, 2011	7.61M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

296.43M

Minimum

Jun 2019

413.31M

Maximum

Mar 2024

372.38M

Average

376.94M

Median

SG&A Expense (TTM) Benchmarks